about
Systemic manifestations of hepatitis C infectionExtrahepatic manifestations of chronic hepatitis C virus infectionMolecular and Bioinformatic Evidence of Hepatitis C Virus Evolution in BrainChronic hepatitis C virus infection and neurological and psychiatric disorders: an overviewHepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicityValue of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients.Neurocognition in individuals co-infected with HIV and hepatitis C.Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection.The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatmentPlasma cytokine levels are related to brain volumes in HIV-infected individuals.Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.Hepatitis C virus infection of neuroepithelioma cell lines.Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.Extrahepatic manifestations of hepatitis C infection: navigating CHASM.Delay discounting is greater among drug users seropositive for hepatitis C but not HIVEthical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.Managing Hepatitis C in Users of Illicit DrugsEvolution of HIV dementia with HIV infection.Co-factors in HIV neurobehavioural disturbances: substance abuse, hepatitis C and aging.Macrophages in hepatitis B and hepatitis C virus infectionsHost and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signalingProtective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis COpioids and HIV/HCV infection.Evidence for association between hepatitis C virus and Parkinson's disease.Serum-derived hepatitis C virus 1a infection of human astrocyte cell line SVG.Evidence of Hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system.Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C.Hepatitis C virus infection: a risk factor for Parkinson's disease.Depressive symptoms are frequent among drug users, but not associated with hepatitis C infection.Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18.Systemic abnormalities in liver disease.In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion.Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury.
P2860
Q26746040-8CC703D5-7932-4EEB-A803-71749F4B5F04Q26767084-CC69DFE7-75AA-4F0B-86FD-D35D523832FFQ27489431-89AF4DA6-BF35-4825-8AD1-4306453B18DEQ28082212-7C86515C-C524-4B0A-8B79-83FFE252944FQ33705274-A79876EB-16BB-486C-A9A2-D135D86B0072Q33889960-3A1F4F29-767D-4283-8ADF-95BA716A6E13Q33917713-018E15C7-1D03-485E-BA8B-B72B1B772283Q34137925-6D80C26F-92D7-4D57-B8B7-1E5C4EA3FEC9Q34174207-CB048B09-F145-44E7-912C-BEB25B46459EQ34345975-704B4FBB-5600-4B54-BF7A-C674172BEE8DQ35125996-F4B63F8E-65D0-4B6A-ABD5-E1DE332514E6Q35201308-076F2B71-8C35-46DB-8338-FF37521FDC67Q35572270-B165379D-DABB-4CAE-9905-0F4FC25CD7C0Q35769113-AEAF1232-0FD6-47D5-A03E-375696017191Q35818245-E8D7C799-EE13-4A1B-B536-AB836FFF148FQ35875495-6E50A07D-716D-48A2-85CB-40478C7A0C33Q36010828-AE906F4B-07C6-4D17-B7C8-3C3DA969E082Q36268936-D774B597-8572-4ACC-B77E-A8C94590C116Q36629372-A7049AE4-C983-4103-BC25-C8E68A0B7B7BQ36948673-F21C6E44-9765-4F17-B9F6-BF6C3D2FA069Q37073653-04022DB3-12B7-4844-A9E2-045E8EF91BC0Q37073662-0AC1174F-1B90-4EE9-86FB-38B9B670F5C1Q37289610-C13987A7-ED31-40A2-9587-F8BF2CE478CFQ37416015-020548B4-33FD-4BA6-B743-02461096A679Q37574403-B040AB28-ED22-4FEE-904A-1A9CC4C36296Q37577536-591A5D56-6052-4F1F-A1B2-EFD3BAC13247Q37607856-26F0789E-9AAA-4C9D-B572-A63C31B41229Q38638550-B6C0B345-548D-441D-B517-4FF2D326A2D1Q38827708-BE65951D-7F73-4A4E-8D3D-02A96A639F44Q40471447-D5454C40-F56F-46F0-844A-2EC70F4945B4Q40924774-63DDBE0F-9233-47F1-841A-986661729281Q41530271-2EC23D51-0709-413F-9FD0-B6100501D6E3Q42210277-CDB2B3B3-DE2A-4B15-8D3D-13C98373B3DBQ42228866-4CE442C1-3684-461C-BF2D-3A4FF2885B51Q42623529-78E99313-43AF-476C-A3F8-37631E83205BQ43047538-713F8966-D1BB-407E-A609-B180336F933CQ43958100-9D013A0A-F2F6-43A6-9A5E-D3B39B30CA23
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Emerging evidence of hepatitis C virus neuroinvasion.
@ast
Emerging evidence of hepatitis C virus neuroinvasion.
@en
type
label
Emerging evidence of hepatitis C virus neuroinvasion.
@ast
Emerging evidence of hepatitis C virus neuroinvasion.
@en
prefLabel
Emerging evidence of hepatitis C virus neuroinvasion.
@ast
Emerging evidence of hepatitis C virus neuroinvasion.
@en
P2093
P1433
P1476
Emerging evidence of hepatitis C virus neuroinvasion.
@en
P2093
Adrienne C Scheck
Debra M Adair
Jeffrey Wilkinson
Jorge Rakela
Marek Radkowski
Tomasz Laskus
P304
P356
10.1097/01.AIDS.0000192083.41561.00
P407
P478
19 Suppl 3
P577
2005-10-01T00:00:00Z